The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Prominent gaps in pediatric and adolescent HIV care translate into priorities that need to be addressed for optimizing care ...

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Allies in Hope, formerly AIDS Foundation Houston, hosted the 36th Annual Walk to End HIV at Sam Houston Park in downtown ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

Without urgent intervention, Kenya risks a surge in new HIV infections, which currently stand at 16,752 annually, NSDCC said.